Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
Wang Rui, Chen Qian, Chen Mengli, Lou Fangding, Zhu Jun, Han Xiaoping, Tan Cie, Pei Baoxiang, Wang Aizhen. Study on the serum bactericidal activity and clinical effects of cefotaxime in patients with hematopathy and infection complication[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(1): 17-19.
1 Klastersky J,Glauser MP,Schimpff SC,et al.Antimicrobial therapy project group for research on treatment of cancer prospective redomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrobial Agents and Chemotherapy,1986,29:263 2 Rubin MC,Hthorn JW,Pizzo PA. contoversies in the management of febrile neutropenic cancer patients. Cancer Invest,1988,6:167 3 Wolffson JS,Swartz MN.Serum bactericidal activity as a monitor of antibiotic theropy. New Engl J Med,1985,312(15):968 4 Marcus RE,Goldman J M.Management of infection in the meutropenic patient. Br Med J,1986,293:406 5 Klastersky J.New antibacterial agents:the role of new pencillins and cephalosporins in the management of infections in the granulocytopenic patients. Clin Haematol,1984,13:587 6 Stratton CW,Weinstein MP,Reller LB.Correlation of serum bactericidal activity with antimicrobial agents level and minimal bactericidal concentration. J Infect DIs,1982,145:160 7 Neu HC.Cephalosporins-cefotaxime 10 year iater,a major drug with continued use. Infection,1991,19(S6):S309 8 王睿.抗生素后效应的研究进展.医药卫生科学技术进展.北京:人民军医出版社,1992:136